Data for Academic Year 2021-2022
This dashboard provides information about COVID-19 within the Johns Hopkins University Community and in the Baltimore area. All data displayed on the dashboard are updated on a daily basis.
The data linked below shows the cumulative counts for positive cases prior to the current academic year. These data are static counts.
Additional information and definitions
Vaccination Data: The “fully vaccinated” category reflects employees and students who have been on campus in the last 30 days and are fully vaccinated. The “in process” category reflects students who are in the process of becoming fully vaccinated in accordance with university policies. Affiliates are excluded from these percentages if they have an approved medical or religious exemption or if they have not been on campus in the last 30 days.
Positive Cases: The number of individuals within the Johns Hopkins University community who have tested positive for COVID-19. Student data includes undergraduates, graduate students, and medical students. Post-doctoral fellows, medical residents and clinical fellows, and medical house staff are included in the employee counts. Johns Hopkins Health System (including Johns Hopkins Hospital) employees are not represented in these counts. The data displayed on the dashboard correspond to date of test result and not date of sample collection.
Tests Conducted: This includes: 1) tests conducted by Johns Hopkins University for asymptomatic (i.e., no symptoms of COVID-19) students and employees; and 2) tests conducted by Johns Hopkins University for students and employees experiencing symptoms associated with COVID-19. The asymptomatic testing program was significantly expanded in January 2021.
Cumulative Tests Conducted: The total number of COVID-19 tests conducted at Johns Hopkins University since Aug. 30, 2021. Student data includes undergraduates, graduate students, and medical students. Post-doctoral fellows, medical residents and clinical fellows, and medical house staff are included in the employee counts. Johns Hopkins Health System (including Johns Hopkins Hospital) employees are not represented in these counts. Historical testing data are available for academic year 2020-2021 and summer 2021.
Test Turnaround Time: The time from sample collection until determination of a test result. Within Johns Hopkins University, turnaround time for test results is typically 24 hours.
Testing Frequency: Starting in January 2021, asymptomatic testing became widely available. In Fall 2021, weekly testing is required for vaccinated undergraduates living in Johns Hopkins residential housing and off-campus in the Baltimore area and vaccinated graduate students who are on campus. Twice-weekly testing is required for students, staff, and faculty with an approved exception to the Covid vaccine mandate. All others may have voluntary weekly testing.
Isolation Housing: Rooms in residential halls and other facilities set aside by Johns Hopkins University for students who test positive for COVID-19. Available housing may be used for either isolation or quarantine.
Quarantine Housing: Rooms in residential halls and other facilities set aside by Johns Hopkins University for students living in Johns Hopkins housing who have had meaningful contact with a person who tested positive for COVID-19. Available housing may be used for either isolation or quarantine.
JHU COVID-19 Operating Status: Johns Hopkins University uses a three-phase operating status:
- Phase 1: Resuming low-density activities
- Continue to comply with strict physical distancing and appropriate mask requirements
- Testing and contact tracing of symptomatic students and employees
- Phase 2: Resuming medium-density activities
- Continued reliance on strict physical distancing and appropriate masking requirements
- Testing and contact tracing of all symptomatic students and employees, and asymptomatic individuals at a rate similar or better than national, state, and local efforts
- Phase 3: Resuming higher-density activities
- Requires widely available vaccine, effective therapeutics, and/or substantial immunity among community